9IA7 | pdb_00009ia7

NMR solution structure of RPRD2 CTD-interacting domain and pT4 RNAPII CTD peptide.

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III HD 600
2	2D 1H-13C HSQC aliphatic	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III HD 600
3	3D 1H-13C NOESY aliphatic	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III 850
4	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III 850
5	3D CBCA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III HD 600
6	3D HNCACB	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III HD 600
7	3D HBHA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III HD 600
8	3D CC(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] RPRD2 CID, 1.5 mM pT4 CTD	90% H2O/10% D2O	100 mM	8	1 Pa	293.15	Bruker AVANCE III HD 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	600
3	Bruker	AVANCE III	850

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	50
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	peak picking	NMRFAM-SPARKY		Lee W, Tonelli M, Markley JL
3	chemical shift assignment	NMRFAM-SPARKY		Lee W, Tonelli M, Markley JL
4	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
5	refinement	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman